Colossal Biosciences logo

Colossal Biosciences Funding & Investors

Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics.

colossal.com

Total Amount Raised: $235,500,000

Colossal Biosciences Funding Rounds

  • Series B

    $150,000,000

    Series B Investors

    Animal Capital
    Bob Nelsen
    WestRiver Group
    PEAK6
    Breyer Capital
    Victor Vescovo
    US Innovative Technology Fund
    Animoca Brands
    Wave Digital Assets
    Elias Montanari
    JAZZ Venture Partners
    In-Q-Tel
    Bold Capital Partners
  • Series A

    $60,000,000

    Series A Investors

    Animal Capital
    Paris Hilton
    Charles Hoskinson
    Breyer Capital
    Untamed Planet
    At One Ventures
    Builders VC
    11:11 Media
    Thomas Tull
    cFund
    Green Sands Equity
    Draper Associates
    Boost VC
    Robert Nelsen
    Animoca Brands
    JAZZ Venture Partners
    Milad Alucozai
    Bold Capital Partners
    First Light Capital
  • Seed

    $15,000,000

    Seed Investors

    Animal Capital
    Breyer Capital
    At One Ventures
    Jeffrey Wilke
    Thomas Tull
    Tony Robbins
    Climate Capital
    Liquid 2 Ventures
    Capital Factory
    Draper Associates
    KittyHawk Ventures
    Global Space Ventures
    Winklevoss Capital
    Rayyan Islam
    JAZZ Venture Partners
    Bold Capital Partners
    First Light Capital
  • Series Unknown

    $10,500,001

Funding info provided by Diffbot.